We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
2344 75 0 ONTY
Emcee:  John Curtis Type:  Unmoderated
Biomira, a speculative bio-tech company, is now marketing itself as “The Cancer Therapy People.” Why? The company currently has, among others drugs, a metastatic breast cancer therapy called Theratope which is in Phase III trials. Phase III is the Food and Drug Administrations final step prior to them either approving or denying a product under review. You should know that Theratope has passed Phases I & II with testing showing a high degree of efficacy.

While Theraptope is not a cure for breast cancer the therapy has been found, via Phases I & II tests, to significantly improve long-term management of the disease. And with zero side effects. These earlier Phase tests have shown to allow those with late stages of the disease to improve both their quality of life and length of survival. The Therotope vaccine works by inducing the body to mount an effective immune response against cancerous cells. The Phase III trial, the company says, follows earlier clinical studies(again, Phases I & II) suggesting significant survival benefits for patients with metastatic breast cancer. In one part of two parallel trials(Phase II), patients who received the vaccine had a median survival of 26.6 months compared with 9.2 months for matched patients in a retrospective control group.

The Phase III trial will ultimately involve 900 patients in approximately 75 sites worldwide. They expect to have all 900 patients logged(filled) and beginning the trial by next summer(year 2000). If all goes well then the first interim analysis of data comes out about six months after the trial fills. Based on Phase I & II results the bulls on this thread think this first interium analysis will vouchsafe earlier results, moving BIOM closer to FDA, and international, approvals for one of the first cancer vaccines by any bio-tech company in the industry.

Theratope, and another Biomira drug for lung cancer are part of a portfolio of synthetic therapies the company has under development. Hence their new company slogan, “The Cancer Therapy People”.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted >> AbbVie, Roche post a big win with a blockbuster FDA OK for scaram(o)uche-6/11/2018
2343ONTY is now Cascadian Theraputics CASC, in case anyone needed an update. This boRon-8/4/2016
2342Oncothyreon Announces Webcast to Review Updated Clinical Data December 8th markRon-12/2/2015
2341Some positive reports popping up. Presentation was this morning. medicalxpress.cRon-5/30/2015
2340what a terrible time to issue...alas.mopgcw-2/9/2015
2339For what it's worth. Maybe one of the experts here can shed more light on tRon-12/12/2014
2338380 data interesting it seems. still holding.mopgcw-12/12/2014
2337I already made that mistake about 15 years ago when it was called Biomira with tIan@SI-12/9/2014
2336>> Looking like a good "January-effect" candidate? << Douscaram(o)uche-12/9/2014
2335<<I haven't seen it once, much less repeatedly.>> Well now, witClarksterh-9/19/2014
2334What do you think, ONTY watchers? The test failure brought the stock down hard.Ron-8/26/2014
2333Ugh. Kirkman didn't have the courage to deliver on his promise of describinscaram(o)uche-6/14/2014
2332Not sure how significant this is, but FYI ______________ Oncothyreon announces Ron-6/2/2014
2331SEATTLE, WA and HAMPTON, NJ, May 29, 2014 /PRNewswire/ - Oncothyreon Inc. ( ONTYnigel bates-5/29/2014
2330another 50 cents and time to reload more trading shares....mopgcw-4/14/2014
2329ONTY has seen buyers the last several weeks. Anyone know whether there was a catRon-3/6/2014 Don't know if that link will work for the entire conversation, scaram(o)uche-12/8/2013
2327Looking like a good "January-effect" candidate? Not l-blp-25, and smascaram(o)uche-11/29/2013
2326Oooops, just noticed, that post was meant to be a private message. :-) Anyway,scaram(o)uche-11/29/2013
2325Hey, Steve.... I admire the fashion in which you communicate. Saw your note ascaram(o)uche-11/19/2013 Phase 1 dose escalation of ONT-10, a therapeutic MUC1scaram(o)uche-11/7/2013
2323So, Walter et al. say that it takes vaccine plus Cy to see survival benefit. Iscaram(o)uche-10/17/2013
2322ya know, ocd is ocd..... <i>While this study showed ratscaram(o)uche-10/17/2013
2321I found this study earlier, but have failed to find it recently. Got back to itscaram(o)uche-10/17/2013
2320Nonos: Where do you live, and what time do you leave the house? ;-) You'rscaram(o)uche110/15/2013
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):